相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Sia Viborg Lindskrog et al.
NATURE COMMUNICATIONS (2021)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurelie Kamoun et al.
EUROPEAN UROLOGY (2020)
Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
Gottfrid Sjodahl et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Identification of Differential Tumor Subtypes of T1 Bladder Cancer
A. Gordon Robertson et al.
EUROPEAN UROLOGY (2020)
Assessment of Luminal and Basal Phenotypes in Bladder Cancer
Charles C. Guo et al.
SCIENTIFIC REPORTS (2020)
Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors
Tuan Zea Tan et al.
EUROPEAN UROLOGY (2019)
Molecular pathology of the luminal class of urothelial tumors
Carina Bernardo et al.
JOURNAL OF PATHOLOGY (2019)
Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype
Jorge Rebola et al.
VIRCHOWS ARCHIV (2019)
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder
Maria Del Carmen Rodriguez Pena et al.
VIRCHOWS ARCHIV (2019)
Comprehensive Gene Expression Analysis in NMIBC Using RNA-seq Reveals New Therapy Strategies
Xiaoliang Chen et al.
FRONTIERS IN ONCOLOGY (2019)
Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts
Gottfrid Sjodahl et al.
JOURNAL OF PATHOLOGY (2019)
Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Nonemuscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors
Judith Bosschieter et al.
CLINICAL GENITOURINARY CANCER (2018)
A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
Nour-al-dain Marzouka et al.
SCIENTIFIC REPORTS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets
Eugene J. Pietzak et al.
EUROPEAN UROLOGY (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Roland Seiler et al.
EUROPEAN UROLOGY (2017)
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review
Viktor Soukup et al.
EUROPEAN UROLOGY (2017)
Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
Gottfrid Sjodahl et al.
JOURNAL OF PATHOLOGY (2017)
In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival
Johannes Breyer et al.
VIRCHOWS ARCHIV (2017)
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
A. Gordon Robertson et al.
CELL (2017)
Heterarchy of transcription factors driving basal and luminal cell phenotypes in human urothelium
Carl Fishwick et al.
CELL DEATH AND DIFFERENTIATION (2017)
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard et al.
CANCER CELL (2016)
Prognostic and Clinicopathological Significance of Downregulated p16 Expression in Patients with Bladder Cancer: A Systematic Review and Meta-Analysis
Xiaoning Gan et al.
DISEASE MARKERS (2016)
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin
Samantha Cambier et al.
EUROPEAN UROLOGY (2016)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Genomic characterization of high-risk non-muscle invasive bladder cancer
Joshua J. Meeks et al.
ONCOTARGET (2016)
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
Vipulkumar Dadhania et al.
EBIOMEDICINE (2016)
FOXA1, GATA3 and PPARγ Cooperate to Drive Luminal Subtype in Bladder Cancer: A Molecular Analysis of Established Human Cell Lines
Joshua I. Warrick et al.
SCIENTIFIC REPORTS (2016)
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma
Oliver Patschan et al.
EUROPEAN UROLOGY (2015)
GATA3: A Multispecific But Potentially Useful Marker in Surgical Pathology A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
Jeffrey S. Damrauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Toward a Molecular Pathologic Classification of Urothelial Carcinoma
Gottfrid Sjodahl et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Utility of GATA3 Immunohistochemistry in Differentiating Urothelial Carcinoma From Prostate Adenocarcinoma and Squamous Cell Carcinomas of the Uterine Cervix, Anus, and Lung
Alex Chang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
Teresa M. Darragh et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjodahl et al.
CLINICAL CANCER RESEARCH (2012)
Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
David Lindgren et al.
PLOS ONE (2012)
Three differentiation states risk-stratify bladder cancer into distinct subtypes
Jens-Peter Volkmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications
Matthias May et al.
EUROPEAN UROLOGY (2010)
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Keith Syson Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma
Xiaobing He et al.
STEM CELLS (2009)
P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma
S Krüger et al.
EUROPEAN UROLOGY (2005)
p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer
SF Shariat et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder
MGW Bol et al.
JOURNAL OF UROLOGY (2003)
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
SJ Pocock et al.
LANCET (2002)
Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases
PGG Chu et al.
MODERN PATHOLOGY (2002)
分享论文
